Danaher Corporation reported $25.6B of revenue over the trailing twelve months, +5.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $25.6B (to Q3 2026). Net income: $4.33B, trailing twelve months to Q3 2026. Free cash flow: $5.73B, trailing twelve months to Q3 2026. Operating margin: 20%, trailing twelve months to Q3 2026.

DHRDanaher Corporation

Healthcare

$230.45+9.6% 1Y

$230.45

$161.9152 weeks$241.54

DHR as reported

Danaher Corporation reported $25.6B of revenue over the trailing twelve months, +5.5% on the year before. 11 reported series are charted on this page, each one as filed.

$25.6B

Revenue, trailing twelve months · to Q3 2026 · +5.5% against the twelve months before

Net income: $4.33B
Net income · +24% year on year · trailing twelve months to Q3 2026
Free cash flow: $5.73B
Free cash flow · +14% year on year · trailing twelve months to Q3 2026
Operating margin: 20%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for DHR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$25.6B	+5.5%	Q3 2026
Net income	$4.33B	+24%	Q3 2026
EPS	$6.11	+26%	Q3 2026
Gross margin	59%	n/a	Q3 2026
Operating margin	20%	n/a	Q3 2026
Net margin	17%	n/a	Q3 2026
ROE	7.4%	n/a	Q3 2026
ROA	4.4%	n/a	Q3 2026
ROIC	5.6%	n/a	Q3 2026
Free cash flow	$5.73B	+14%	Q3 2026
P/E	37.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.